← Back to Search

SHARING Choices for Advance Care Planning and Dementia

N/A
Waitlist Available
Led By Jennifer Wolff, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is testing whether the SHARING Choices program can help prepare people and their families for Advance Care Planning (ACP). The program includes access to a facilitator trained to lead ACP discussions, as well as patient-family agenda-setting to align perspectives about the role of family and stimulate discussion about ACP.

Eligible Conditions
  • Advance Care Planning
  • Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Occurrence of potentially burdensome procedures reported within 6 months
Proportion of patients 65 and older with documentation of any advance directive in the Electronic Health Record (EHR)
Secondary outcome measures
Occurrence of potentially burdensome procedures reported within 6 months preceding death

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SHARING ChoicesExperimental Treatment1 Intervention
Components of SHARING Choices include: A letter from the clinic introducing an initiative to prepare persons and families for Advance Care Planning (ACP); Access to a facilitator trained to lead ACP discussions; Patient-family agenda-setting to align perspectives about the role of family and stimulate discussion about ACP; Facilitated registration to the patient portal (for patient and family) as desired; Education & resources about Alzheimer's Disease and Related Dementias (ADRD) for clinic staff.
Group II: Usual careActive Control1 Intervention
Usual care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SHARING Choices
2021
N/A
~64990

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,259 Previous Clinical Trials
14,755,665 Total Patients Enrolled
Medstar Health Research InstituteOTHER
189 Previous Clinical Trials
50,585 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
27,940,126 Total Patients Enrolled
8 Trials studying Advance Care Planning
13,711 Patients Enrolled for Advance Care Planning

Media Library

SHARING Choices Clinical Trial Eligibility Overview. Trial Name: NCT04819191 — N/A
Advance Care Planning Research Study Groups: SHARING Choices, Usual care
Advance Care Planning Clinical Trial 2023: SHARING Choices Highlights & Side Effects. Trial Name: NCT04819191 — N/A
SHARING Choices 2023 Treatment Timeline for Medical Study. Trial Name: NCT04819191 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open positions within this research initiative?

"This medical trial, which was posted on March 1st 2021 and revised July 22nd 2022, is no longer open for recruitment. Nevertheless, there are 409 other studies currently seeking participants for their research."

Answered by AI

How many venues is this investigation currently running in?

"54 trial sites are currently active for this clinical study, including MedStar Medical Group 18111 Prince Philip in Olney, Johns Hopkins Community Physicians - Howard County in Columbia and MedStar Medical Group at Laurel in Laurel. Additionally, there is a range of other facilities that have been recruited to participate."

Answered by AI
Recent research and studies
~15915 spots leftby Apr 2025